The higher prices of its treatment of multiple sclerosis help the German pharmaceutical company Merck first-quarter net profit rose 54%. Merck also saw stronger material sales of liquid crystal display, and raised its earnings forecast that this year will achieve its 2014 target. Optimistic net profit came to EUR 266 million yuan ($ 345 million) in the first three months of this year from a year earlier to 172.7 euros. Total revenue rose 4.4% to $ 276 million. The company said on Tuesday that its multiple sclerosis treatment Rebif sales increased by 6% to ? 454 million, due to higher prices, higher sales in the U.S. and in Europe. Merck, headquartered in Darmstadt, Germany, Merck, is a different company is headquartered in the United States of


Other News:
Kenya asks U.N. Security Council to end Hague case against president
Higher prices for MS drug help drug firm Merck
Long troubled by school bullying, Japan now eyes zero tolerance
Deadly bomb strikes civilian area in east Libya
Search continues in Kansas for girl presumed dead
Icahn, Southeastern challenge Dell takeover plan
Stocks waver in early trading on Wall Street
European, U.S. retailers split on Bangladesh reform plan